Dates
Monday, 26 June 2017 - Tuesday, 27 June 2017
Meeting Code
HRT1725
Would you like more information?
Kate Tynan
kate.tynan@healthroundtable.org
THE PROBLEM: International consensus:
10% of blood transfusions are appropriate
30% have uncertain benefits
60% inappropriate
Large variation in transfusion practice among Roundtable members.
THE OPPORTUNITY: Patient Blood Management is an important safety and
quality initiative with the potential to improve patient outcomes whilst also
reducing hospital expenditure.
• Red Blood Cell (RBC) transfusion is independently associated with increased morbidity, mortality, hospital and ICU length of stay, and increased cost.
• On average, RBC transfused patients stay 2.5 days longer, with increased
odds ratio of death of 1.7.
• A recent West Australian study estimated the total hospital- associated cost of RBC transfusion across a five hospital health service to be $77 million per year.
• Blood product costs will be devolved to public hospitals and incorporated
into the ABF framework.
• Existing wide variation: RBC transfusion rates vary from 8% to 93% in cardiac surgery, and 9-92% in orthopaedics. A large number of transfusions may be inappropriate and avoidable.
• Australian NSQHS Standard 7 requires that hospitals have systems in place to ensure safe and appropriate prescribing and use of blood and blood products, and that they are consistent with national evidence-based
guidelines.
THE SOLUTION: Can we afford NOT to do Patient Blood Management? Western
Australia is a world exemplar in PBM, we can all implement workable solutions based on the WA strategies and experience.
Click here for brochure